共 39 条
[2]
Cavicchioni G, 1998, ARCH PHARM, V331, P368, DOI 10.1002/(SICI)1521-4184(199811)331:11<368::AID-ARDP368>3.3.CO
[3]
2-2
[4]
Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2
[J].
JOURNAL OF PEPTIDE RESEARCH,
2002, 60 (04)
:223-231
[5]
A hydrophilic residue at position 2 can improve specific biological responses in fMLP-OMe analogs
[J].
JOURNAL OF PEPTIDE RESEARCH,
2001, 58 (03)
:257-262
[6]
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[7]
Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO
[8]
2-6
[9]
DENTINO AR, 1991, J BIOL CHEM, V266, P18460
[10]
DIFFERENTIAL STIMULATION OF NEUTROPHIL FUNCTIONS BY PYRITHIOXINE
[J].
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY,
1993, 15 (05)
:641-646